← All companies
AbCellera Biologics Inc.
ABCL - CIK 0001703057
Market cap$1.55 B
Rank#2293
SEC filings297
The table below shows AbCellera Biologics Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $77.06M | $83.16M | $92.44M | $159.27M | $126.64M | $148.31M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $7.86M | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.